{"title":"Insomnia in the Elderly: Evaluation and Management","authors":"","doi":"10.33591/sfp.48.2.u3","DOIUrl":"https://doi.org/10.33591/sfp.48.2.u3","url":null,"abstract":"","PeriodicalId":85774,"journal":{"name":"The Singapore family physician","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47052689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Behavioural and Psychological Symptoms of Dementia – Assessment and Management","authors":"V. Mok, W. Ling","doi":"10.33591/sfp.47.2.u1","DOIUrl":"https://doi.org/10.33591/sfp.47.2.u1","url":null,"abstract":"Behavioural and psychological symptoms of dementia (BPSD) are defined as signs and symptoms of disturbed perception, thought content, mood or behaviour. BPSD are very common regardless of the type of dementia and is present in nearly all people with dementia over the course of their illness. A local study conducted in 2013 found the prevalence of BPSD be 67.9 percent. BSPD are associated with major adverse of BPSD involves the understanding of how the interplay of various factors (persons with dementia, caregivers, and environment) may cause BPSD and that interventions must be tailored to each individual. The first line of management should always be non-pharmacological interventions where possible. The ultimate goal in treatment of BPSD is to alleviate persons with dementia.","PeriodicalId":85774,"journal":{"name":"The Singapore family physician","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47562499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Inflammatory Bowel Disease – An Update for Primary Care Physicians","authors":"C. Lim, E. Salazar, M. Tan, W. Chan","doi":"10.33591/sfp.48.1.uo1","DOIUrl":"https://doi.org/10.33591/sfp.48.1.uo1","url":null,"abstract":"Inflammatory bowel disease (IBD) is a chronic, idiopathic, inflammatory disorder of the gastrointestinal tract that is typically categorised into Crohn’s disease and ulcerative colitis. Traditionally, IBD was regarded as a disease of the western world. Newer epidemiological studies suggest that, with the turn of the 21st century, IBD has become a global disease with rising incidence in newly industrialised countries in Asia, Africa, and South America. There are also advances in the diagnostics and therapeutic armamentarium of IBD. In this review, we provide an update on the epidemiology, clinical features, investigations, and management of IBD. We also highlight the importance of vaccination in IBD and provide practical points for family physicians.","PeriodicalId":85774,"journal":{"name":"The Singapore family physician","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43679188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Updates in DM and CKD management: Are SGLT2 Inhibitors the answer?","authors":"","doi":"10.33591/sfp.47.8.e","DOIUrl":"https://doi.org/10.33591/sfp.47.8.e","url":null,"abstract":"","PeriodicalId":85774,"journal":{"name":"The Singapore family physician","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48233198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"How Can We Halt-CKD in Primary Care?: Clinical Care Paths to Manage Chronic Kidney Disease","authors":"Dr Ooi Xi Yan, Yeo See Cheng","doi":"10.33591/sfp.47.8.u3","DOIUrl":"https://doi.org/10.33591/sfp.47.8.u3","url":null,"abstract":"Chronic kidney disease (CKD) is a major health problem in Singapore, and its incidence is projected to rise. Slowing the progression of CKD is paramount in enabling patients to live longer without complications or the need for kidney replacement therapy, allaying the health and economic burden of CKD on individuals and the society. Effective treatment strategies comprise of lifestyle, dietary, and medical management, which include dietary sodium restriction, physical activity, smoking cessation, blood pressure and glucose control, and use of renin-angiotensin system inhibitors to reduce albuminuria. The Holistic Approach in Lowering and Tracking Chronic Kidney Disease (HALTCKD) programme is a concerted effort to delay the progression of CKD through a multi-faceted, integrated approach. Here, we outline the rationale and aims of these recommendations, provide practical tips for implementing these interventions, and highlight future opportunities in our ongoing battle against CKD.","PeriodicalId":85774,"journal":{"name":"The Singapore family physician","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42629108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"I’d like to write another book\" – Integrated Primary Care for an At-Risk Elder (IPCARE) Requiring Expedited Peritoneal Dialysis from Rapid Progression of End-Stage Renal Failure","authors":"Gabrielle N. Yee","doi":"10.33591/sfp.47.8.up1","DOIUrl":"https://doi.org/10.33591/sfp.47.8.up1","url":null,"abstract":"An 84-year-old gentleman with stage 5 chronic kidney disease (CKD) from diabetic nephropathy required community hospital step-down after repeated hospitalisations for fluid overload. Renal function decline outpaced appointments for initiation of peritonealdialysis (PD). Biological and psychosocial barriers to dialysis initiation had to be tackled across settings in a collaborative, multi-disciplinary manner aligning various stakeholders. These included initial delirium that affected his mental capacity regarding placement and treatment, and concern regarding potential contraindications to PD. At the patient level, family physicians (FPs) are wellplaced to assess the mental capacity of patients, advocating and communicating their capacitated preferences to all stakeholders, collaborating with relevant subspecialists for dialysis initiation, and comanaging with community FP partners as medical experts in the anticipatory transitional care for patients with rapidly progressive end-stage renal failure (ESFR). The role of IPCARE as a systemic key enabler is also discussed. SFP2021; 47(8) : 31-35","PeriodicalId":85774,"journal":{"name":"The Singapore family physician","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48176337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Are Our Type 2 Diabetes Patients Sufficiently Protected from Cardiorenal Complications?","authors":"AProf Goh Su-Yen","doi":"10.33591/sfp.47.8.u1","DOIUrl":"https://doi.org/10.33591/sfp.47.8.u1","url":null,"abstract":"Cardiovascular and renal outcome trials categorically demonstrate the benefits of SGLT2 inhibitors (SGLT2i). Various pharmacotherapy algorithms recommend early use of SGLT2i, especially among those with existing cardiovascular disease, heart failure, or kidney disease. Despite a widening spectrum of patient eligibility, treatment gaps and clinical inertia still exist.","PeriodicalId":85774,"journal":{"name":"The Singapore family physician","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44792075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"PATIENTS WITH SEVERE ASTHMA NEED ACCURATE DIAGNOSIS AND CORRECT TREATMENT: HOW CAN WE ACHIEVE THAT?","authors":"Dr Chan Kwok Wai Adrian","doi":"10.33591/sfp.47.7.u3","DOIUrl":"https://doi.org/10.33591/sfp.47.7.u3","url":null,"abstract":"CHAN KWOK WAI ADRIAN Respiratory Physician Mouth Elizabeth Novena Hospital Singapore ABSTRACT Since asthma is frequently encountered in the primary care setting, it is important to distinguish uncontrolled or difficult-to-control asthma from severe asthma. Severe asthma is defined as asthma that is uncontrolled despite adherence with an optimised high-dose combination of inhaled corticosteroids (ICS) and long-acting beta-agonists (LABA) therapy, or that requires high-dose ICS– LABA to remain controlled. This article highlights simple decisions and diagnosis steps that may help primary care physicians and general practitioners to identify patients who could benefit from tertiary care specialist assessment once other factors, such as inhaler technique, adherence, and comorbidities have been evaluated. It also briefly discusses the impact of oral corticosteroids (OCS) use and the challenges of the COVID-19 lockdown on asthma management.","PeriodicalId":85774,"journal":{"name":"The Singapore family physician","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45926570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}